NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128446&wire=1 or contact Joseph E. Levi, Esq.

On February 07, 2024, Millrose Properties (NYSE: MRP; $26.74; Market Capitalization: $3.5 billion), and Lennar Corporation (NYSE: LEN, $121.94; Market Capitalization: $32.2 billion) started regular-way trading. MRP opened at $23.49, made an intraday high of $27.07, and a low of $22.26 before closing at $26.74.

Shares of Fortive Corp FTV were climbing in early trading on Monday, despite the company reporting disappointing fourth-quarter revenues.

Atlanta, GA, Feb. 10, 2025 (GLOBE NEWSWIRE) -- ScanTech AI Systems, Inc. (NASDAQ: STAI) (the “Company” or “ScanTech AI”), a publicly-traded innovator of next-generation checkpoint security scanning solutions, today reaffirmed its commitment to transforming the security screening industry through AI-driven technologies amid strong operational fundamentals and global tailwinds. The is addressing what its CEO Dolan Falconer believes may be “short-sighted trading activity by certain market participants, together with potential high-volume short activity” that has pressured the Company's share price in recent weeks.

Gold was shining bright Monday morning, as investors monitored the tariff front for expected developments this week.

France's antitrust agency is investigating Microsoft over concerns that it is degrading the quality of results when smaller rivals pay to use Bing technology in their own search-engine products, Bloomberg reported on Monday.

PEGA's fourth-quarter 2024 results are likely to benefit from increased adoption of GenAI Blueprint tool and Pega Cloud platform.

LITTLETON, Colo.--(BUSINESS WIRE)--CPI Card Group Inc. to Release Fourth Quarter and Full Year 2024 Results on March 4, 2025.

Friedman Industries, Incorporated's Q3 2025 earnings show falling volumes and unprofitable operations, confirming trends observed since early 2024. The company's market cap is $120 million with a high P/E ratio, making its valuation difficult to justify. Friedman cannot cover interest costs at current volumes, but has sufficient net working capital to avoid immediate financial issues.

TGI's total sales in the third quarter of fiscal 2025 surpass the Zacks Consensus Estimate by 10.1%. The top line also increases 10.7% from the year-ago level.

FTV reports strong fourth-quarter fiscal 2024 results, with both revenues and earnings increasing year over year.

PPC's Q4 results are likely to gain from strategic investments, strong foodservice growth and an innovative product pipeline, reinforcing its competitive edge.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/astrazeneca-plc-lawsuit-submission-form?prid=128429&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Electronic Arts Inc. ("Electronic Arts Inc.") (NASDAQ:EA) concerning possible violations of federal securities laws. On January 22, 2025, EA issued a press release pre-announcing their preliminary Q3 FY25 results and announcing a guide-down from the company's prior expectations.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Innovative Industrial Properties, Inc. (NYSE:IIPR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/innovative-industrial-properties-inc-lawsuit-submission-form?prid=128442&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128433&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your ESSA Pharma Inc. (NASDAQ:EPIX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/essa-pharma-inc-lawsuit-submission-form?prid=128436&wire=1 or contact Joseph E. Levi, Esq.

Big pharma has come under a lot of scrutiny from regulators and consumers as sentiment sours on the industry. As such, the market can be unforgiving when companies even slightly miss expectations or forecasts.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Pacira BioSciences, Inc. (NASDAQ:PCRX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pacira-biosciences-inc-lawsuit-submission-form?prid=128435&wire=1 or contact Joseph E. Levi, Esq.